Investigation of New Therapeutic Targets in Undifferentiated Endometrial Sarcoma.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28125812)

Published in Gynecol Obstet Invest on January 27, 2017

Authors

Min-Hyun Baek1, Jeong-Yeol Park, Chae Chun Rhim, Jong-Hyeok Kim, Yangsoon Park, Kyu-Rae Kim, Joo-Hyun Nam

Author Affiliations

1: Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.

Articles by these authors

Trabectedin plus pegylated liposomal Doxorubicin in recurrent ovarian cancer. J Clin Oncol (2010) 3.33

The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma. Gynecol Oncol (2011) 2.76

Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes. Gynecol Oncol (2008) 1.89

Differentiation of subtypes of renal cell carcinoma on helical CT scans. AJR Am J Roentgenol (2002) 1.88

Laparoscopic management of early uterine cancer: 10-year experience in Asan Medical Center. Gynecol Oncol (2007) 1.81

Imaging findings of complications and unusual manifestations of ovarian teratomas. Radiographics (2008) 1.53

Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin. Gynecol Oncol (2012) 1.49

Usefulness of lymphoscintigraphy and intraoperative gamma probe detection in the identification of sentinel nodes in cervical cancer. Eur J Nucl Med Mol Imaging (2003) 1.41

Pathologic risk factors for predicting residual disease in subsequent hysterectomy following LEEP conization. Gynecol Oncol (2007) 1.40

Invasive colorectal micropapillary carcinoma: an aggressive variant of adenocarcinoma. Hum Pathol (2006) 1.30

Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer. Gynecol Oncol (2007) 1.23

Malignant transformation of mature cystic teratoma of the ovary: experience at a single institution. Eur J Obstet Gynecol Reprod Biol (2008) 1.09

Surgical management of borderline ovarian tumors: The role of fertility-sparing surgery. Gynecol Oncol (2009) 1.06

Papillary mucinous metaplasia of the endometrium as a possible precursor of endometrial mucinous adenocarcinoma. Mod Pathol (2012) 1.06

Stage IIIC epithelial ovarian cancer classified solely by lymph node metastasis has a more favorable prognosis than other types of stage IIIC epithelial ovarian cancer. J Gynecol Oncol (2008) 1.06

Pure non-gestational choriocarcinoma of the ovary diagnosed by DNA polymorphism analysis. Pathol Int (2006) 1.06

Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989-2007. J Cancer Res Clin Oncol (2008) 1.05

Comparison of the validity of magnetic resonance imaging and positron emission tomography/computed tomography in the preoperative evaluation of patients with uterine corpus cancer. Gynecol Oncol (2008) 1.04

The impact of tumor morcellation during surgery on the outcomes of patients with apparently early low-grade endometrial stromal sarcoma of the uterus. Ann Surg Oncol (2011) 1.03

Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition. J Gynecol Oncol (2013) 1.02

Tumor cells resistant to a microtubule-depolymerizing hemiasterlin analogue, HTI-286, have mutations in alpha- or beta-tubulin and increased microtubule stability. Biochemistry (2004) 1.02

Preoperative diagnosis of mature cystic teratoma with malignant transformation: analysis of imaging findings and clinical and laboratory data. Arch Gynecol Obstet (2006) 1.01

Expression profile of histone deacetylases 1, 2 and 3 in ovarian cancer tissues. J Gynecol Oncol (2008) 0.99

Clinical relevance of gain-of-function mutations of p53 in high-grade serous ovarian carcinoma. PLoS One (2013) 0.99

Is complete surgical staging necessary in patients with stage I mucinous epithelial ovarian tumors? Gynecol Oncol (2006) 0.98

Conservation of the class I beta-tubulin gene in human populations and lack of mutations in lung cancers and paclitaxel-resistant ovarian cancers. Mol Cancer Ther (2002) 0.97

Further stratification of risk groups in patients with lymph node metastasis after radical hysterectomy for early-stage cervical cancer. Gynecol Oncol (2010) 0.97

Fertility-sparing surgery for young women with early-stage epithelial ovarian cancer. Gynecol Obstet Invest (2013) 0.96

The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass. Gynecol Oncol (2012) 0.96

Menthol regulates TRPM8-independent processes in PC-3 prostate cancer cells. Biochim Biophys Acta (2008) 0.96

A unifying concept of trophoblastic differentiation and malignancy defined by biomarker expression. Hum Pathol (2007) 0.96

Neoadjuvant chemotherapy with paclitaxel plus platinum followed by radical surgery in early cervical cancer during pregnancy: three case reports. Jpn J Clin Oncol (2010) 0.95

Laparoscopic versus open radical hysterectomy in patients with stage IB2 and IIA2 cervical cancer. J Surg Oncol (2013) 0.94

Extrarenal teratoid Wilms' tumor: two cases in unusual locations, one associated with elevated serum AFP. Pathol Int (2010) 0.94

Vaginal cuff dehiscence after hysterectomy. Int J Gynaecol Obstet (2013) 0.94

Peroxiredoxin 6 overexpression attenuates cisplatin-induced apoptosis in human ovarian cancer cells. Cancer Invest (2011) 0.94

Comparison of laparoscopy and laparotomy in surgical staging of early-stage ovarian and fallopian tubal cancer. Ann Surg Oncol (2008) 0.94

Differential gene expression profiling in human cholangiocarcinoma cells treated with Clonorchis sinensis excretory-secretory products. Parasitol Res (2008) 0.93

Comparison of outcomes between radical hysterectomy followed by tailored adjuvant therapy versus primary chemoradiation therapy in IB2 and IIA2 cervical cancer. J Gynecol Oncol (2012) 0.93

Surgical staging and adjuvant chemotherapy in the management of patients with adult granulosa cell tumors of the ovary. Gynecol Oncol (2011) 0.93

High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys (2009) 0.92

Pulmonary benign metastasizing leiomyoma associated with intravenous leiomyomatosis of the uterus: clinical behavior and genomic changes supporting a transportation theory. Int J Gynecol Pathol (2008) 0.92

Primary yolk sac tumor of the omentum: a case report and review of the literature. Arch Gynecol Obstet (2008) 0.92

Update on treatment of uterine sarcoma. Curr Opin Obstet Gynecol (2010) 0.92

Unfavorable prognosis of small cell neuroendocrine carcinoma of the uterine cervix: a retrospective matched case-control study. Int J Gynecol Cancer (2010) 0.91

Clinical significance of tumor volume in endometrial cancer: a Japan-Korea cooperative study. Gynecol Oncol (2013) 0.91

Vaccination with a human papillomavirus (HPV)-16/18 AS04-adjuvanted cervical cancer vaccine in Korean girls aged 10-14 years. J Korean Med Sci (2010) 0.91

Risk assessment tool for distant recurrence after platinum-based concurrent chemoradiation in patients with locally advanced cervical cancer: a Korean gynecologic oncology group study. J Clin Oncol (2012) 0.91

A low-risk group for lymph node metastasis is accurately identified by Korean gynecologic oncology group criteria in two Japanese cohorts with endometrial cancer. Gynecol Oncol (2013) 0.91

Laparoscopic versus open radical hysterectomy for elderly patients with early-stage cervical cancer. Am J Obstet Gynecol (2012) 0.90

Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer. Obstet Gynecol (2013) 0.90

Follicular stimulating hormone enhances Notch 1 expression in SK-OV-3 ovarian cancer cells. J Gynecol Oncol (2010) 0.90

Surgical practice patterns in endometrial cancer: results of the Korean Gynecologic Oncology Group survey. J Gynecol Oncol (2009) 0.89

Efficacy of taxane and platinum-based chemotherapy guided by extreme drug resistance assay in patients with epithelial ovarian cancer. J Gynecol Oncol (2009) 0.89

The efficacy of conservative management after conization in patients with stage IA1 microinvasive cervical carcinoma. Acta Obstet Gynecol Scand (2009) 0.89

Clinical presentation of endometrioid epithelial ovarian cancer with concurrent endometriosis: a multicenter retrospective study. Cancer Epidemiol Biomarkers Prev (2010) 0.88

Long-term outcomes after fertility-sparing laparoscopic radical trachelectomy in young women with early-stage cervical cancer: an Asan Gynecologic Cancer Group (AGCG) study. J Surg Oncol (2014) 0.88

Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy. J Pathol (2014) 0.87

The effect of combined treatment with cisplatin and histone deacetylase inhibitors on HeLa cells. J Gynecol Oncol (2010) 0.87

Renal lymphangioma manifested as a solid mass on ultrasonography and computed tomography. J Ultrasound Med (2002) 0.87

Role of PET or PET/CT in the post-therapy surveillance of uterine sarcoma. Gynecol Oncol (2008) 0.86

Pure primary squamous cell carcinoma of the ovary: a report of two cases and review of the literature. Int J Gynecol Pathol (2010) 0.86

Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002). Eur J Cancer (2012) 0.86